跳至主要内容
临床试验/EUCTR2005-002741-39-DE
EUCTR2005-002741-39-DE
进行中(未招募)
不适用

A PROSPECTIVE, CONTROLLED, RANDOMIZED, PATIENT AND EVALUATOR BLINDED STUDY TO EVALUATE PAIN AND FURTHER DISABLING COMPLICATIONS IN PATIENTS UNDERGOING LICHTENSTEIN TECHNIQUE FOR PRIMARY INGUINAL HERNIA REPAIRBY FIXING THE MESH WITH TISSUCOL/TISSEEL FIBRIN SEALANT VERSUS SUTURES - TI.ME.LI. study

Pr Giampiero CAMPANELLI Università di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggior0 个研究点目标入组 328 人2006年1月2日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
nilateral, uncomplicated primary inguinal hernia repair
发起方
Pr Giampiero CAMPANELLI Università di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggior
入组人数
328
状态
进行中(未招募)
最后更新
14年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2006年1月2日
结束日期
待定
最后更新
14年前
研究类型
Interventional clinical trial of medicinal product

研究者

发起方
Pr Giampiero CAMPANELLI Università di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggior

入排标准

入选标准

  • 1\. Written signed informed consent obtained from the subject prior to participation in the study.
  • 2\. Active males over the age of 18 years and till 70 years. Active is defined by having normal daily activities.
  • 3\. Experiencing an uncomplicated unilateral primary inguinal hernia.
  • 4\. Subjects eligible for elective inguinal hernia repair using Lichtenstein technique.
  • Are the trial subjects under 18?
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

排除标准

  • 1\. Recurrent, bilateral, scrotal, incarcerated or femoral hernias.
  • 2\. Hernia types L3 and M3 according the European Hernia Society classification assessed pre or intra\-operatively
  • 3\. BMI equal or more than 35
  • 4\. Concomitant abdominal surgery
  • 5\. Ongoing long term analgesic or steroid treatment
  • 6\. Patients under Clopidogrel or Warfarin (can be switched to LMW sub\-cutaneous heparin)
  • 7\. Known abuse of alcohol or drugs
  • 8\. Liver cirrhosis (Child C)
  • 9\. Hypersensitivity to bovine aprotinin
  • 10\. Known immunodeficiency

结局指标

主要结局

未指定

相似试验

进行中(未招募)
不适用
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures. - TIMELI 001nilateral, uncomplicated primary inguinal hernia repairClassification code 10022020
EUCTR2005-002741-39-DKniversità di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione328
进行中(未招募)
1 期
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures.
EUCTR2005-002741-39-ESPr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est328
进行中(未招募)
不适用
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with Tissucol/Tisseel fibrin sealant versus sutures - TI.ME.LI. studySubjects requiring a unilateral tension-free hernioplasty by Lichtenstein technique.MedDRA version: 6.1Level: PTClassification code 10022020
EUCTR2005-002741-39-ITOSPEDALE MAGGIORE DI MILANO IRCCS328
进行中(未招募)
1 期
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with fibrin sealant versus sutures. - TIMILI 001
EUCTR2005-002741-39-GBProf. Giampiero CAMPANELLI328
招募中
3 期
Study on the prevention of atopic dermatitis symptoms in children with a high risk of the disease through the regular use of a moisturizing skin cream
2024-513289-21-00INFECTOPHARM Arzneimittel und Consilium GmbH360